APA (7th ed.) Citation

B, O., B, H., HP, H., HB, K., T, C., L, D., . . . HT, O. (2020). Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment. Molecular therapy. Nucleic acids, 21, 1006. https://doi.org/10.1016/j.omtn.2020.07.030

Chicago Style (17th ed.) Citation

B, O'Callaghan, et al. "Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment." Molecular Therapy. Nucleic Acids 21 (2020): 1006. https://doi.org/10.1016/j.omtn.2020.07.030.

MLA (9th ed.) Citation

B, O'Callaghan, et al. "Antisense Oligonucleotide Therapeutic Approach for Suppression of Ataxin-1 Expression: A Safety Assessment." Molecular Therapy. Nucleic Acids, vol. 21, 2020, p. 1006, https://doi.org/10.1016/j.omtn.2020.07.030.